Ryan M. Conrad, PhD

home / authors / ryan-m-conrad-phd

Articles

March 19th 2014

Do Strict Formularies Replicate Failure for Patients With Schizophrenia?

Dana P. Goldman, PhD Riad Dirani, PhD John Fastenau, MPH, RPh Ryan M. Conrad, PhD

This study measures the impact of Medicaid formulary restrictions on the rate at which patients who failed on a drug therapy for schizophrenia return to the same therapy.

September 27th 2012

Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Jennie H. Best, PhD John A. Romley, PhD Dana P. Goldman, PhD Ryan M. Conrad, PhD Anne L Peters, MD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Terra Wonsettler, PharmD, MBA | Image credit: LinkedIn photo

Published: December 19th 2024 | Updated: December 26th 2024

The Dangerous Intersection of Breast Cancer and Cardiovascular Disease: A Call for Improved Prevention

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions